Air Liquide's unit Schulke buys Healthcare Antisepsis from Ethicon
This acquisition is in line with the development strategy for Air Liquide's hygiene business activity and allows the company to develop its business in Asia
BS B2B Bureau B2B Connect | Paris, France
Healthcare Antisepsis’ hygiene product line offers a broad range of solutions for skin disinfection, particularly in hospital settings, which generated revenue of nearly Euro 40 million in 2014. The products are distributed in numerous countries in the Asia-Pacific region, under the Microshield brand name.
Air Liquide will acquire all of the assets related to the HAS business in this region, which will be progressively transferred to Air Liquide, starting May 2015. In addition to complementing Schulke’s products, this acquisition represents a major geographic development of Air Liquide’s hygiene business activity.
Pascal Vinet, vice president healthcare global operations and member of Air Liquide group’s executive committee, said, “This acquisition is in line with the development strategy for Air Liquide’s hygiene activity. It will allow us to develop our business in Asia, which has significant potential for growth and to gain a foothold in new geographic markets.”
Also Read
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 02 2015 | 4:47 PM IST